Use of ulipristal for treating uterine fibroids

Details for Australian Patent Application No. 2009209652 (hide)

Owner Laboratoire HRA-Pharma The United States of America as represented by The Secretary, Department of Health and Human Services

Inventors Ulmann, Andre; Gainer, Erin; Nieman, Lynnette; Blithe, Diana

Agent Davies Collison Cave

Pub. Number AU-A-2009209652

PCT Pub. Number WO2009/095418

Priority 12/021,610 29.01.08 US

Filing date 28 January 2009

Wipo publication date 6 August 2009

International Classifications

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61P 5/36 (2006.01) Drugs for disorders of the endocrine system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/095418 Priority application(s): WO2009/095418

3 February 2011 Amendment Made

  The nature of the amendment is: Amend the invention title to read Use of ulipristal acetate for treating uterine fibroids

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009209658-Oral care composition for combating dentine hypersensitivity

2009209651-Method for enhancing pet food palatability